Minnesota teens build app to help patients getting infusions find community

Luke Wachowiak sat at his dining room table on a recent Saturday afternoon, scrolling on his phone as a nurse placed an IV in ...

Eisai submits Marketing Authorisation Variation to EMA for intravenous maintenance dosing every four weeks with Leqembi® (lecanemab)

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have submitted a proposed Marketing Authorisation Variation to the European Medicines Agency (EMA) for a once ...
Medscape

New Stroke Guidance Expands Treatment Options, Offers First Pediatric Stroke Guidance

Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...
dvm360

Novel niclosamide prodrug shows promise against canine osteosarcoma

Niclosamide is an old antiparasitic with documented anticancer activity in laboratory models, but its clinical use for cancer has been limited by poor solubility and bioavailability. The authors ...

The anti-aging supplement Kim Kardashian and Bryan Johnson have in common — it’s more effective than NAD+

This is 40-something. Kim Kardashian, 45, has tried to cling to her youth by undergoing skin-tightening treatments, traveling ...

Shopper Blog: Three-legged red panda brings inspiring story to Zoo Knoxville

Shopper News brings you the latest happenings in your community ...

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

Insider Transaction: Roger E Susi Sells $503K Worth Of iRadimed Shares

It was reported on January 27, that Roger E Susi, CEO at iRadimed (NASDAQ: IRMD) executed a significant insider sell, according to an SEC filing. What Happened: A Form 4 filing from the U.S.

QTX-2101 Awarded FDA Fast Track Designation for the Treatment of Acute Promyelocytic Leukemia

QTX-2101 is an investigational, oral arsenic trioxide therapy that has not yet been approved by any regulatory authority. Its ...
TMCnet

FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under ...

LEQEMBI is currently approved in 53 countries and regions and is under regulatory review in 7 countries. In August 2025, the US FDA approved LEQEMBI IQLIK 360 mg for weekly subcutaneous maintenance ...

Namita Thapar takes IV iron therapy due to low ferritin: What is it and how can it help women with iron deficiency

Shark Tank India's Namita Thapar recently shared a video of herself from her IV iron therapy. She talked about suffering from ...